Drug Shortage Report for JAMP-LOSARTAN HCTZ
| Report ID | 23918 |
| Drug Identification Number | 02408252 |
| Brand name | JAMP-LOSARTAN HCTZ |
| Common or Proper name | Losartan HCTZ |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
| Strength(s) | 25MG 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-09-01 |
| Estimated end date | |
| Actual end date | 2018-05-18 |
| Shortage status | Resolved |
| Updated date | 2018-05-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.